Abstract. Mitogen-activated protein kinase-activated protein kinase 2 (MK2) and its mediated inflammation are involved in various diseases, including spinal cord injury (ScI). Ultrashortwave (USW) radiation has previously been reported to exert a protective effect on ScI. In the present study, through a series of reverse transcription-quantitative polymerase chain reaction (RT-qPcR), western blot and immunofluorescence assay, it was found that MK2 and tumor necrosis factor (TNF)-α/interleukin (IL)-1β were elevated in patients with ScI and in H 2 O 2 -treated c8-d1A cells. Through gene level and protein level detection by using of RT-qPcR, western blot, immunofluorescence assay and terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling assay, it was demonstrated that USW radiation inhibited the expression of MK2/TNF-α/IL-1β and suppressed the apoptosis of H 2 O 2 -treated C8-D1A cells. Furthermore, it was confirmed that the overexpression of MK2 reversed the protective effect of USW on c8-d1A cells, which indicated that USW achieved its function via regulation of the MK2/TNF-α/IL-1β pathway. Finally, using a constructed in vivo model and a series of RT-qPCR, western blot and IHC detection, it was confirmed that USW suppressed the expression of MK2 to promote functional recovery following ScI.
Introduction
Traumatic spinal cord injury (ScI) is a problematic disease that results in a substantial burden on human society, and has a marked effect on the mind and body of patients (1, 2) . In general, the pathological process of ScI is divided into two stages: The acute phase and subacute phase, in which secondary damage to central nervous system (cNS) tissue occurs due to a variety of factors, including ischemia, hemorrhage, excitotoxic damage and inflammation (3) . It is widely accepted that innumerable cytokines and signaling pathways mediating the inflammatory response contribute to the secondary damage following ScI (4-7).
Mitogen-activated protein kinase (MAPK)-activated protein kinase 2 (MK2) has been reported as a direct substrate of p38α and p38β MAPKs, and is a novel molecular target for the anti-inflammatory response (8) . Based on an animal study of Parkinson's disease, Gómez-Nicola found that MK2-knockout mice exhibited reduced neurotoxicity and reduced neuroinflammation (9) . In addition, Tietz et al revealed that MK2 is key in the regulation and limitation of the immune response in the cNS (10) . To date, there have been few studies on MK2 and ScI. Ghasemlou et al reported that a lack of MK2 contributed to a reduction in tissue damage following ScI and an improvement in locomotor recovery (11) .
In our previous study, it was found that bone marrow stromal cell (BMSC) transplantation combined with exposure to USW (USW) radiation promoted tissue repair and functional recovery following ScI. It was also demonstrated that the transplantation of BMSCs combined with exposure to USW radiation inhibited Ed1, a marker of activated macrophages, and the expression of glial fibrillary acidic protein, which indicated a weakening of the inflammatory response (12) . In another previous study, it was found that USW therapy promotes nerve axon regeneration and Schwann cell proliferation (13) . The present study focused on the effect of USW radiation on astrocyte inflammation. Using H 2 O 2 -treated astrocyte ScI cell models and construction of an ScI rat model, it was revealed that USW radiation inhibited the MK2-mediated inflammatory response and promoted the repair of SCI. The findings of the present study provide an improved understanding of USW radiation in the treatment of ScI. (14) , and these were then harvested for subsequent detection. For the USW radiation exposure, a USW device (Shanghai Electrical device company, Shanghai, china) was used for USW radiation exposure at a frequency of 40.68 MHz, with a maximum and actual export power of 11.32 W.
Plasmid construction and transfection. The full length MK2 was amplified and cloned into the KpnI and XhoI restriction sites (Promega corporation, Madison, WI, USA) of the pcdNA3.1 vector (Invitrogen; Thermo Fisher Scientific, Inc.) to synthetize an MK2-overexpression plasmid (pcdNA3.1-MK2). The pcdNA3.1-MK2 plasmids were transfected into the cultured c8-d1A cells in the presence of H 2 O 2 to construct the MK2-overexpression ScI cell model by using of Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.). The pcdNA3.1 vector was transfected into cells in the control ScI cell model. Total RNAs and total proteins were harvested 24 h following transfection for further detection.
Immunofluorescence analysis. The immunofluorescence procedure was performed as previously reported (15) . Briefly, the c8-d1A cells (5x10 5 ) were passaged onto glass coverslips (0.8x0.8 cm) and cultured to 50-60% confluence. Following rinsing twice with PBS, the coverslips were fixed with 4% paraformaldehyde for 15 min and blocked with 5% BSA (Cell Signaling Technologies, Inc., danvers, MA, USA) for 1 h at room temperature. Subsequently, rabbit anti-MK2 antibody (Abcam, cambridge, UK; 1:100; cat. no. ab131504) was added for incubation at 4˚C overnight. The following day, following incubation with fluorescent secondary antibodies (1:200; cat. no. ab150081, Abcam) at room temperature for 1 h, the coverslips were observed under a fluorescent microscope (Leica Microsystems GmbH, Wetzlar, Germany). Images were captured and analyzed using Image-Pro Plus 6.0 software (Media cybernetics, Inc., Rockville, Md, USA).
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis. All the procedures were performed as described previously (16) . In brief, total RNA was extracted using TRIzol (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. cdNA was synthesized using the PrimeScript RT Reagent kit (Takara Biotechnology Co., Ltd., dalian, china). The RT-qPcR analysis was performed using SYBR-Green Premix Ex Taq (Takara Biotechnology co., Ltd.) on Light cycler 480 system (Roche diagnostics, Basel, Switzerland) according to the manufacturer's protocol. The expression of tumor necrosis factor (TNF)-α, interleukin (IL)-1β and MK2 were calculated using β-actin as an internal control by the 2 -ΔΔcq method (17) . The primers used in the present study were as follows: TNF-α, forward 5'-ccA cGT cGT AGc AGc AAA ccA ccA AG-3' and reverse 5'-cAG GTA cAT GGG cTc cTc ATA cc-3'; IL-1β, forward 5'-ccc AAc TGG TAc ATc AGc Acc Tc-3' and reverse 5'-GAc AcG GAT Tcc ATG GTG AAG Tc-3'; MK2, forward 5'-GAc ATG TGG Tcc TTG GGT GTc ATc ATG-3' and reverse 5'-GAG ATG GcA AGG ccG TGA TTG GAA TAG-3'; β-actin, forward 5'-AGT GTG AcG TGG AcA Tcc GcA AAG-3' and reverse 5'-ATc cAc ATc TGc TGG AAG GTG GAc-3'. The thermocycling conditions were: Pre-denaturation at 95˚C for 15 sec, followed by a denaturation at 95˚C for 5 sec, annealing and extension at 60˚C for 30 sec for 45 cycles.
Western blot analysis. Total protein from the cells and tissue specimens were extracted using RIPA lysis buffer (Santa cruz Biotechnology, Inc., Dallas, TX, USA). Protein concentration was quantified using the BCA protein assay kit (Santa Cruz Biotechnology, Inc.) A total of 40 µg proteins were subjected to 10% SDS-PAGE and transferred onto a PVDF membrane, and then blocked by 5% BSA (Cell Signaling Technologies, Inc.) for 1 h at room temperature. Each membrane was incubated with primary antibodies at 4˚C overnight, followed by incubation with secondary antibodies [goat anti-rabbit IgG horseradish peroxidase (HRP), 1:2,000; cat. no. ab205718; Abcam] at room temperature for 1 h the following day. The following antibodies were used: Rabbit anti-MK2 antibody (1:500); rabbit anti-TNF-α antibody (1:500; ab6671; Abcam) and rabbit anti-GAPdH antibody (1:10,000; ab128915; Abcam). After three washes with TBST, an ECL Western Blotting Substrate Kit (cat. no. ab65623; Abcam) was applied for chemiluminescence imaging by using of Image J2X software (Rawak Software Inc., Stuttgart, Germany).
Terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling (TUNEL) assay. cell apoptosis was determined using a TUNEL assay, as previously described (18) . Briefly, the c8-d1A cells were seeded on coverslips and were then fixed using 4% paraformaldehyde for 30 min, followed by permeabilizing with 0.1% Triton X-100 for 2 min on ice. The cells were then labeled using a TUNEL kit (Nanjing Keygen Biotech Co., Ltd., Nanjing, China) according to the manufacturer's protocol. The apoptotic index was calculated using the following formula: Apoptotic index = (total number of apoptotic cells/total number of cells) x 100%.
Establishment of animal models and Basso-Beattie-Bresnahan (BBB) evaluation. All the procedures were performed as previously reported (12) . A total of 48 Sprague-dawley female rats (average weight: 180-220 g) with an average age of 12-weeks-old, provided by the Experimental Animal center at Shengjing Hospital of china Medical University, were randomly divided into three groups (n=16 each): Sham-operated group, control group (ScI animals) and USW group (ScI animals exposed to USW radiation). All animals were housed in a condition of 20-25˚C with 6-80% humidity and all animals were maintained under a 12 h light/dark cycle with free access to food and water. Spinal cord contusion was inflicted using Allen's method (Allen, 1911) when the animals were under intraperitoneal anesthesia (12) . A 2-cm midline incision was made over the T9-T11 spinal region, and the soft tissue and T9-T11 vertebrae were removed. Laminectomy was performed at the T10 level under a surgical microscope, avoiding dura matter laceration. The spinal cord was injured using a modified Allen's impactor, where a guided 9-g rod was dropped 10 cm onto the exposed dura mater, representing moderate ScI. Following recovery from anesthesia, the rats exhibited paralysis of both hind limbs, urine and stool disorder, mental weakness, and slow and poor feeding, and received manual bladder expression twice daily until recovery of sphincter control. For the postoperative treatment of animals in the USW group, a pair of disc electrodes 4 cm in diameter was placed bilaterally on the T9-T11 vertebrae at a distance of 2 cm from the skin. The USW device (Shanghai Electrical device company) was operated at a frequency of 40.68 MHz, with maximum and actual export powers of 40 and 11.32 W, respectively. USW treatment was executed daily with a radiating exposure of 7 min/time until the animals were sacrificed.
A 21-point BBB scale was used to assess the hind limb locomotor function (19) . The tests were performed prior to surgery and at 1-week intervals following ScI for 4 weeks. The animals were placed individually on an open field (radius, 90 cm) and allowed to move freely for 4 min. Performance was evaluated by two experienced observers blinded to the treatment groups.
Immunohistochemistry. All the procedures were performed as described previously (20) . In brief, tissue slides (4-µm thick) were incubated with a TNF-α/MK2 primary antibody at 4˚C overnight, and subsequently incubated with biotinylated secondary antibodies (2 µg/ml; Abcam) at 37˚C for 30 min. This was followed by streptavidin-HRP complex incubation and diaminobenzidine tetrahydrochloride (Abcam) staining, and hematoxylin (Abcam) counterstaining. All slides were assessed independently under a Leica dMILLEd inverted microscope (Olympus corporation, Tokyo, Japan) by two experienced pathologists, who were blinded to patient clinical pathology and other information. The expression level of TNF-α/MK2 was evaluated as described previously (21) .
Statistical analysis. All data are presented as the mean ± standard deviation and were analyzed using GraphPad Prism 5.0 software (GraphPad Software, Inc., La Jolla, cA, USA). P<0.05 was considered to indicate a statistically significant difference. Two-way analysis of variance was used to compare groups (between-subject) and time following surgery (within-subject and repeated measures), and one-way analysis of variance was used to examine differences in the between-subject factor. A post hoc Bonferroni test was used when necessary to examine specific differences between groups.
Results

MK2 is elevated in patients with SCI and H 2 O 2 -treated
C8-D1A cells. The expression of MK2 was detected in serum specimens of 20 patients with ScI and in paired serum specimens of 20 patients without SCI. As shown in Fig. 1A and B, the expression of MK2 was elevated in serum specimens of patients with ScI, compared with that in serum specimens of patients without ScI (P<0.01). Secondly, H 2 O 2 was used to simulate an astrocyte inflammation cell model. As shown in Fig. 1c and d, the expression levels of TNF-α and IL-1β, two common markers of inflammation, were significantly increased in the H 2 O 2 -treated c8-d1A cells, compared with those in the control group (P<0.01). Thirdly, the expression of MK2 was measured at the cellular level. As shown in Fig. 1E -G, the expression of MK2 was also elevated in the H 2 O 2 -treated C8-D1A cells (P<0.01). All the above findings indicated that an elevated level MK2 was present in patients with ScI and in the H 2 O 2 -treated astrocyte cell model.
USW radiation inhibits the inflammatory response and apoptosis in C8-D1A cells.
In our previous study, it was found that USW therapy combined with BMSC transplantation promoted the functional recovery of ScI in rats (12) . Therefore, the present study examined whether USW radiation was able to alleviate the astrocyte inflammatory response following SCI at the cellular level. The expression levels of TNF-α and IL-1β were detected in each group. As shown in Fig. 2A and B, compared with the control group, the expression levels of TNF-α and IL-1β in the H 2 O 2 group and H 2 O 2 + USW group were elevated (P<0.01). compared with the H 2 O 2 group, the expression levels of TNF-α and IL-1β in the H 2 O 2 + USW group were significantly decreased (P<0.05). These results indicated that USW radiation alleviated the inflammatory response of the astrocytes following USW exposure. In addition, the expression of MK2 was measured in the above-mentioned cell models. As shown in Fig. 2c and d , USW radiation inhibited the expression of MK2 in the H 2 O 2 -treated c8-d1A cells (P<0.05). Furthermore, the effect of USW treatment on the apoptosis of c8-d1A cells was determined using a TUNEL assay. As shown in Fig. 2E , USW treatment inhibited cell apoptosis in the H 2 O 2 -treated c8-d1A cells (P<0.01). The above results supported the hypothesis that USW radiation alleviates the inflammatory response and apoptosis following H 2 O 2 intervention, and it was revealed that USW radiation had a protective effect in astrocytes following H 2 O 2 intervention.
Upregulation of MK2 reverses the protective effect USW radiation on C8-D1A cells. As described above, it was found that USW radiation alleviated the inflammatory response and inhibited the expression of MK2 in H 2 O 2 -treated c8-d1A cells. Therefore, whether the protective effect of USW radiation on the inflammatory response was achieved through the MK2 pathway was investigated. An MK2-overexpression plasmid (pcdNA3.1-MK2) was constructed, and the constructed pcdNA3.1-MK2 plasmid was then transfected into the USW radiation-treated c8-d1A cells. As shown in Fig. 3A-c , transfection of the cells with pcDNA3.1-MK2 led to a significant elevation in the expression of MK2 in the USW radiation-treated C8-D1A cells (P<0.01). It was also confirmed that the elevation of MK2 promoted the expression of TNF-α and IL-1β with the presence of USW radiation ( Fig. 3d-G; P<0.01 ). In addition, the results revealed that the overexpression of MK2 promoted c8-d1A cell apoptosis in the presence of USW radiation ( Fig. 3H; P<0.01) . Therefore, the findings revealed that the upregulation of MK2 reversed the protective effect USW radiation on the c8-d1A cells.
USW suppresses the expression of MK2 and promotes functional recovery following SCI in vivo.
To further confirm the protective effect of USW radiation on ScI in vivo, an ScI rat model was constructed as previously reported (12) . USW radiation was applied in treating the rats in the USW group (Fig. 4A) . As shown in Fig. 4B , compared with the sham surgery group, the average BBB scores of the control group and USW group were markedly decreased, indicating that the animal model was successfully constructed. When comparing the differences between the control group and USW group, it was found that the BBB scores in the USW group were prominently higher than those in the control group (Fig. 4B) . These results demonstrated that USW promoted the functional recovery of ScI. The expression level of TNF-α was then determined in each group by IHc, RT-qPcR and western blot analyses. As shown in Fig. 4c and d, compared with the control group, USW radiation treatment markedly inhibited the expression of TNF-α and IL-1β. The expression of MK2 was determined using the same methods and, as shown in Fig. 4F , USW radiation markedly suppressed the expression of MK2 in vivo. Finally, apoptosis in the animal model was determined. As shown in Fig. 4F , USW radiation significantly inhibited apoptosis in the ScI rats.
In brief, as the mechanism in Fig. 5 shows, the results described above confirmed that USW radiation promoted SCI recovery by inhibiting inflammation via suppression of the MK2/TNF-α pathway.
Discussion
Inflammation is an essential defense mechanism, which is vital in protecting against various pathogenic attacks, including ScI (3, 22, 23) . As a downstream substrate of p38 MAPKs and a novel molecular target of the anti-inflammatory response, MK2 is located at human chromosome 1q32.1 and functions as a key regulator in the treatment of inflammatory diseases, particularly in nervous system inflammation (8, 24) . Ghasemlou et al reported that a lack of MK2 promoted locomotor recovery and reduced tissue damage following ScI (11). Kroner et al reported that MK2 facilitated TNF-induced M1 macrophage polarization following ScI (25) . The present study focused on the expression and function of MK2 following ScI. It was found that the expression of MK2 was elevated in patients with ScI and in an H 2 O 2 -treated astrocyte cell model, which confirmed the role of MK2 as an inflammatory factor in ScI, as previously reported. In addition, through a constructed MK2-overexpression plasmid, the present study demonstrated that the elevation of MK2 reversed the protective effect of USW radiation on c8-d1A cells via promotion of the expression of TNF-α and IL-1β.
As a downstream gene of MK2, TNF-α and IL-1β are known markers of various inflammatory conditions (26, 27) . Tietz et al reported that TNF-α and IL-6 signaling were mediated by the MK2 pathway, and that the knockdown of MK2 inhibited the expression of TNF-α/IL-6 and protected against cerulein-induced pancreatitis (28) . In the present study, TNF-α and IL-1β were selected as molecular markers in ScI-related inflammation. The cellular and animal experiments confirmed that TNF-α and IL-1β were elevated following the different inflammation-related interventions. Of note, it was revealed again that the up-regulation of MK2 led to elevated expression levels of TNF-α and IL-1β, indicating that MK2 was upstream of these genes.
As a type of high frequency electric field, USW radiation exerts its function via a mechanism of heating and non-heating effects. A low field intensity of electric field (40 mW/cm 2 ) caused by a small dose of USW radiation may lead to full extension or contraction on cells and may result in biological effects via specific stimulation on cells or tissues. Pelletier et al reported that the direct exposure to current electric field stimulation resulted in morphological and molecular changes of brain cells (29) . In the present study, it was confirmed that USW radiation alleviated the inflammatory response in H 2 O 2 -treated c8-d1A cells. In addition, it was confirmed that USW inhibited H 2 O 2 -induced apoptosis in c8-d1A cells. Furthermore, through in vivo experiments, the present study also demonstrated the protective effect of USW radiation on the constructed ScI rat model. In terms of the molecular mechanism, it was shown that USW radiation suppressed the expression of MK2 in the in vivo and in vitro experiments.
The inflammatory response of SCI and its treatment are complex issues. The findings of the present study revealed that USW promoted ScI recovery and alleviation of the inflammatory response following SCI via the suppression of MK2; however, the detailed mechanism of this effect on MK2 occurs remains to be fully elucidated. The results of the present study may provide a novel target in the molecular treatment of ScI. 
